Margo and Robert Keith Donate $1.5 Million to Endow Chair Honoring Fox Chase Cancer Center's Immediate Past President Robert C. Young, M.D.
PHILADELPHIA (July 10, 2007) — Margot and Robert Keith of Newtown Square, Pa., have endowed a new faculty chair at Fox Chase Cancer Center in honor of its immediate past president, Robert C. Young, MD, of Chestnut Hill in Philadelphia. The new The Robert C. Young, MD, Endowed Chair in Cancer Research will help stimulate innovative studies leading to novel treatments, diagnostic and prevention techniques.
"An endowed chair at an institution like Fox Chase is really significant and to create one that will carry the name of Robert C. Young, going forward, is a tremendous honor for us," said Margot Wallace Keith, a member of the Fox Chase board of directors since 2001. "We're very excited about this opportunity.
"The Robert C. Young chair acknowledges Bob's contribution to Fox Chase and the fight that goes on at that institution every day against this awful disease. We're hoping that other people will join us so this endowment will grow over time and continue to support that work."
Young stepped down June 1 after serving as president for 18 and a half years. His legacy includes the first comprehensive program of cancer prevention research and a three-phase plan charting the future expansion of the institution.
His successor, , who came to Fox Chase from Massachusetts General Hospital and the Dana-Farber Cancer Institute, immediately named Young to the newly created post of chancellor. In this role, Young will lead several efforts, including continuing as chairman of the National Cancer Institute's Board of Scientific Advisors and advocating for Fox Chase Cancer Center at both the national and state levels.
"This was a once in a lifetime opportunity for us to do something singularly important enough to recognize Bob and all the great things that he has done," said Robert E. Keith Jr., who is the managing general partner, president and CEO of TL Ventures and also board chairman of Safeguard Scientifics and the Internet Capital Group, Inc. "My father died of cancer when I was quite young-10 years old, to be exact-and one of the things that sort of motivates Margot and me to support this in Bob's name is to prevent cancer in the future so that kids will not have to endure it for either themselves or for their parents."
"As parents and grandparents, we can't think of a better place to invest our money than in an institution such as Fox Chase that strives all day, every day, to create a future free of cancer for our children and our grandchildren," added Margot Keith.
The Keiths formally announced their endowment of the new chair at the annual board of directors dinner June 21.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.